Sign Out
Kavolred is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.
Kavolred is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD) not on dialysis with serum phosphorus ≥ 1.78 mmol/l.
Kavolred should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.
